Inflammasomes regulate microglial caspase-1 activation and subsequent neuroinflammatory processes in brain pathology. In the present study, we have identified inflammasomes causing caspase-1 activation following stimulation of microglia with lysophosphatidylcholine (LPC), a proinflammatory lipid generated under pathological conditions in the brain. LPC-induced caspase-1 activation in microglia was found to depend on LPS prestimulation, inflammasome NLRP3 and adaptor molecule ASC. Furthermore, knockdown of inflammasome NLRC4 inhibited LPC-stimulated caspase-1 activity in microglia, suggesting the requirement of two inflammasomes for optimal caspase-1 activity.
Introduction
Caspase-1 has been considered as a potential therapeutic target in a variety of neurological diseases (Vezzani et al., 2010; Walsh et al., 2014; Song et al., 2017) . It converts biologically inactive precursors of the proinflammatory cytokines interleukin (IL)-1β, IL-18 and IL-33 into their mature, biologically active forms, which play a pivotal role in promoting neuroinflammatory processes (Eder, 2009; Garlanda et al., 2013) . Mechanisms underlying caspase-1 activation in microglia are not completely understood. Multiple pathways can lead to caspase-1 activation in microglia, while intracellular protein complexes called inflammasomes are major components of the activation cascade of caspase-1 (Walsh et al., 2014; Song et al., 2017) .
Lysophosphatidylcholine (LPC) is a proinflammatory lipid, which is released from apoptotic cells or produced under inflammatory or ischemic conditions in the brain as a result of enhanced phospholipase A 2 activity (Farooqui and Horrocks, 2006; Drzazga et al., 2014) . LPC can cause microglial recruitment during brain development (Xu et al., 2016) and microglial activation in brain pathology (Inose et al., 2015) . We have previously demonstrated that LPC induces caspase-1 activation in microglia (Stock et al., 2006) , which depends on Na + influx, reactive oxygen species production and intact lipid rafts (Schilling and Eder, 2010, 2011) . Here, we have extended our studies and identified inflammasomes regulating LPC-stimulated caspase-1 activity in microglia.
Materials and methods

Materials
The following drugs were used in this study: synthetic L-α-lysophosphatidylcholine (LPC), palmitoyl (16:0); lipopolysaccharide (LPS) from E. coli 055:B5 (both from Sigma-Aldrich, Germany). Stock solutions of 30 mM LPC and 1 mg/ml LPS were prepared in H 2 O.
Cells
All experiments were performed on the microglial cell line BV-2. Cells were cultured permanently in DMEM supplemented with 10% FCS and 2 mM L-glutamine as described previously (Stock et al., 2006) . Cells were split twice a week, and were plated on glass coverslips at a density of 1 × 10 5 /ml for subsequent experiments. During experiments, cells were maintained in an extracellular solution containing (in mM): NaCl, 130; KCl, 5; CaCl 2 , 2; MgCl 2 , 1; HEPES, 10; D-glucose, 10 (pH 7.4) as described previously (Stock et al., 2006; Schilling and Eder, 2010, 2011 
